The efficacy of basic fibroblast growth factor-loaded poly(lactic-co-glycolic acid) nanosheet for mouse wound healing

Shimpo Aoki, Mao Fujii, Toshinori Fujie, Keisuke Nishiwaki, Hiromi Miyazaki, Daizoh Saitoh, Shinji Takeoka, Tomoharu Kiyosawa, Manabu Kinoshita

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Although human recombinant basic fibroblast growth factor (bFGF) is widely used for wound healing, daily treatment with bFGF is required because of its short half-life. An effective controlled-release system of bFGF is, therefore, desired in clinical settings. To investigate the efficacy of a bFGF-loaded nanosheet for wound healing, focusing on the controlled-release of bFGF, bFGF-loaded poly(lactic-co-glycolic acid) (PGLA) nanosheets were developed, and their in vitro release profile of bFGF and their in vivo efficacy for wound healing were examined. A polyion complex of positively charged human recombinant bFGF and negatively charged alginate was sandwiched between PLGA nanosheets (70 nm thick for each layer). The resulting bFGF-loaded nanosheet robustly adhered to silicon skin by observation using a microscratch test. bFGF was gradually and continuously released over three days in an in vitro incubation study. Treatment with the bFGF-loaded nanosheets (every 3 day for 15 days) as well as with a conventional bFGF spray effectively promoted wound healing of mouse dorsal skin defects with accelerated tissue granulation and angiogenesis, although the dose of bFGF used in the treatment with the bFGF nanosheets was approximately 1/20 of the sprayed bFGF. In conclusion, we developed a bFGF-loaded nanosheet that sustained a continuous release of bFGF over three days and effectively promoted wound healing in mice.

Original languageEnglish
Pages (from-to)1008-1016
Number of pages9
JournalWound Repair and Regeneration
Volume25
Issue number6
DOIs
Publication statusPublished - 2017 Nov 1

Fingerprint

Fibroblast Growth Factor 2
Wound Healing
polylactic acid-polyglycolic acid copolymer
Skin
Granulation Tissue
Silicon
Half-Life

ASJC Scopus subject areas

  • Surgery
  • Dermatology

Cite this

Aoki, S., Fujii, M., Fujie, T., Nishiwaki, K., Miyazaki, H., Saitoh, D., ... Kinoshita, M. (2017). The efficacy of basic fibroblast growth factor-loaded poly(lactic-co-glycolic acid) nanosheet for mouse wound healing. Wound Repair and Regeneration, 25(6), 1008-1016. https://doi.org/10.1111/wrr.12604

The efficacy of basic fibroblast growth factor-loaded poly(lactic-co-glycolic acid) nanosheet for mouse wound healing. / Aoki, Shimpo; Fujii, Mao; Fujie, Toshinori; Nishiwaki, Keisuke; Miyazaki, Hiromi; Saitoh, Daizoh; Takeoka, Shinji; Kiyosawa, Tomoharu; Kinoshita, Manabu.

In: Wound Repair and Regeneration, Vol. 25, No. 6, 01.11.2017, p. 1008-1016.

Research output: Contribution to journalArticle

Aoki, S, Fujii, M, Fujie, T, Nishiwaki, K, Miyazaki, H, Saitoh, D, Takeoka, S, Kiyosawa, T & Kinoshita, M 2017, 'The efficacy of basic fibroblast growth factor-loaded poly(lactic-co-glycolic acid) nanosheet for mouse wound healing', Wound Repair and Regeneration, vol. 25, no. 6, pp. 1008-1016. https://doi.org/10.1111/wrr.12604
Aoki, Shimpo ; Fujii, Mao ; Fujie, Toshinori ; Nishiwaki, Keisuke ; Miyazaki, Hiromi ; Saitoh, Daizoh ; Takeoka, Shinji ; Kiyosawa, Tomoharu ; Kinoshita, Manabu. / The efficacy of basic fibroblast growth factor-loaded poly(lactic-co-glycolic acid) nanosheet for mouse wound healing. In: Wound Repair and Regeneration. 2017 ; Vol. 25, No. 6. pp. 1008-1016.
@article{6d88f4ce7dae45e9afd8789ebfc4a80e,
title = "The efficacy of basic fibroblast growth factor-loaded poly(lactic-co-glycolic acid) nanosheet for mouse wound healing",
abstract = "Although human recombinant basic fibroblast growth factor (bFGF) is widely used for wound healing, daily treatment with bFGF is required because of its short half-life. An effective controlled-release system of bFGF is, therefore, desired in clinical settings. To investigate the efficacy of a bFGF-loaded nanosheet for wound healing, focusing on the controlled-release of bFGF, bFGF-loaded poly(lactic-co-glycolic acid) (PGLA) nanosheets were developed, and their in vitro release profile of bFGF and their in vivo efficacy for wound healing were examined. A polyion complex of positively charged human recombinant bFGF and negatively charged alginate was sandwiched between PLGA nanosheets (70 nm thick for each layer). The resulting bFGF-loaded nanosheet robustly adhered to silicon skin by observation using a microscratch test. bFGF was gradually and continuously released over three days in an in vitro incubation study. Treatment with the bFGF-loaded nanosheets (every 3 day for 15 days) as well as with a conventional bFGF spray effectively promoted wound healing of mouse dorsal skin defects with accelerated tissue granulation and angiogenesis, although the dose of bFGF used in the treatment with the bFGF nanosheets was approximately 1/20 of the sprayed bFGF. In conclusion, we developed a bFGF-loaded nanosheet that sustained a continuous release of bFGF over three days and effectively promoted wound healing in mice.",
author = "Shimpo Aoki and Mao Fujii and Toshinori Fujie and Keisuke Nishiwaki and Hiromi Miyazaki and Daizoh Saitoh and Shinji Takeoka and Tomoharu Kiyosawa and Manabu Kinoshita",
year = "2017",
month = "11",
day = "1",
doi = "10.1111/wrr.12604",
language = "English",
volume = "25",
pages = "1008--1016",
journal = "Wound Repair and Regeneration",
issn = "1067-1927",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - The efficacy of basic fibroblast growth factor-loaded poly(lactic-co-glycolic acid) nanosheet for mouse wound healing

AU - Aoki, Shimpo

AU - Fujii, Mao

AU - Fujie, Toshinori

AU - Nishiwaki, Keisuke

AU - Miyazaki, Hiromi

AU - Saitoh, Daizoh

AU - Takeoka, Shinji

AU - Kiyosawa, Tomoharu

AU - Kinoshita, Manabu

PY - 2017/11/1

Y1 - 2017/11/1

N2 - Although human recombinant basic fibroblast growth factor (bFGF) is widely used for wound healing, daily treatment with bFGF is required because of its short half-life. An effective controlled-release system of bFGF is, therefore, desired in clinical settings. To investigate the efficacy of a bFGF-loaded nanosheet for wound healing, focusing on the controlled-release of bFGF, bFGF-loaded poly(lactic-co-glycolic acid) (PGLA) nanosheets were developed, and their in vitro release profile of bFGF and their in vivo efficacy for wound healing were examined. A polyion complex of positively charged human recombinant bFGF and negatively charged alginate was sandwiched between PLGA nanosheets (70 nm thick for each layer). The resulting bFGF-loaded nanosheet robustly adhered to silicon skin by observation using a microscratch test. bFGF was gradually and continuously released over three days in an in vitro incubation study. Treatment with the bFGF-loaded nanosheets (every 3 day for 15 days) as well as with a conventional bFGF spray effectively promoted wound healing of mouse dorsal skin defects with accelerated tissue granulation and angiogenesis, although the dose of bFGF used in the treatment with the bFGF nanosheets was approximately 1/20 of the sprayed bFGF. In conclusion, we developed a bFGF-loaded nanosheet that sustained a continuous release of bFGF over three days and effectively promoted wound healing in mice.

AB - Although human recombinant basic fibroblast growth factor (bFGF) is widely used for wound healing, daily treatment with bFGF is required because of its short half-life. An effective controlled-release system of bFGF is, therefore, desired in clinical settings. To investigate the efficacy of a bFGF-loaded nanosheet for wound healing, focusing on the controlled-release of bFGF, bFGF-loaded poly(lactic-co-glycolic acid) (PGLA) nanosheets were developed, and their in vitro release profile of bFGF and their in vivo efficacy for wound healing were examined. A polyion complex of positively charged human recombinant bFGF and negatively charged alginate was sandwiched between PLGA nanosheets (70 nm thick for each layer). The resulting bFGF-loaded nanosheet robustly adhered to silicon skin by observation using a microscratch test. bFGF was gradually and continuously released over three days in an in vitro incubation study. Treatment with the bFGF-loaded nanosheets (every 3 day for 15 days) as well as with a conventional bFGF spray effectively promoted wound healing of mouse dorsal skin defects with accelerated tissue granulation and angiogenesis, although the dose of bFGF used in the treatment with the bFGF nanosheets was approximately 1/20 of the sprayed bFGF. In conclusion, we developed a bFGF-loaded nanosheet that sustained a continuous release of bFGF over three days and effectively promoted wound healing in mice.

UR - http://www.scopus.com/inward/record.url?scp=85041720848&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041720848&partnerID=8YFLogxK

U2 - 10.1111/wrr.12604

DO - 10.1111/wrr.12604

M3 - Article

C2 - 29315978

AN - SCOPUS:85041720848

VL - 25

SP - 1008

EP - 1016

JO - Wound Repair and Regeneration

JF - Wound Repair and Regeneration

SN - 1067-1927

IS - 6

ER -